eMedCodes logo

Simulect - basiliximab

Navigation: NDC > Supplier starting with: N > NOVARTIS PHARMACEUTICALS CORPORATION
Field Value
NDC Code: 0078-0331
Proprietary Name: Simulect
Suffix:
Non-Proprietary Name: basiliximab
Dosage Form: INJECTION, POWDER, FOR SOLUTION
Method: INTRAVENOUS
Original Marketing Date: 12-05-1998
Category Name: BLA
Application Number: BLA103764
Labeler: NOVARTIS PHARMACEUTICALS CORPORATION
Substance Name: BASILIXIMAB
Active Numerator Strength: 20
Active Ingredient Unit: mg/5mL
Pharm Classes: Interleukin 2 Receptor Antagonists [MoA],Interleukin 2 Receptor-directed Antibody Interactions [MoA],Interleukin-2 Receptor Blocking Antibody [EPC]
DEA Schedule: